Phase II study of segmental transcatheter arterial chemoembolization using iodinated oil mixed with cisplatin powder for unresectable hepatocellular carcinoma

Phase 2

• Conditions: hepatocellular carcinoma

• Registration Number: JPRN-UMIN000020810
• Lead Sponsor: ara Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

obvious development of feeding artery from an extrahepatic artery (e.g., inferior phrenic artery, inferior adrenal artery, internal mammary artery) to tumor; previous pancreato-biliary surgery or endoscopic sphincteropapillotomy; serious complications other than chronic hepatitis or liver cirrhosis; a history of allergy to iodine-containing agents or contrast media; extrahepatic metastasis; concomitant malignancy; active clinically serious infections; advanced arteriovenous shunt or arterioportal shunt; pregnant or lactating women, or women of childbearing potential; and other serious medical conditions.

Study & Design

• Study Type: Interventional
• Study Design: Not specified